+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

LAMEA Negative Pressure Wound Therapy Market Size, Share & Trends Analysis Report By End-Use, By Product, By Type (Pressure Ulcers, Diabetic Foot Ulcers, Venous Leg Ulcers, Burn Wounds, and Others), By Country and Growth Forecast, 2023 - 2030

  • PDF Icon

    Report

  • 105 Pages
  • January 2024
  • Region: Africa, Middle East
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5928416
The Latin America, Middle East and Africa Negative Pressure Wound Therapy Market would witness market growth of 8.1% CAGR during the forecast period (2023-2030).

NPWT is employed in the fixation of flaps and grafts, promoting their adherence and viability. By applying negative pressure to secure these tissue transfers, NPWT helps reduce the risk of graft failure, ensuring successful integration and wound closure. Orthopedic surgeries, like joint replacements and spinal procedures, often involve extensive incisions and potential complications. NPWT aids in orthopedic wound management by facilitating optimal healing conditions, reducing the risk of infections, and supporting the recovery of patients undergoing these procedures.

NPWT is often used as a bridge to definitive wound closure, allowing healthcare providers to manage complex wounds over an extended period. This approach is especially beneficial in cases where immediate closure is not feasible and staged wound management is required. NPWT is utilized in the management of wounds associated with peripheral arterial disease. NPWT contributes to limb salvage efforts in patients with compromised vascular circulation by promoting tissue perfusion and supporting angiogenesis.

NPWT has been increasingly adopted in hospitals, clinics, and wound care centers across the UAE. The UAE has invested significantly in developing advanced healthcare infrastructure, including adopting cutting-edge medical technologies. Ongoing advancements in NPWT technology, including the development of portable and user-friendly devices, contribute to the accessibility and ease of use of NPWT in healthcare settings in the UAE. Additionally, Venous leg ulcers are a significant health concern globally, and their prevalence tends to increase with factors such as aging populations, sedentary lifestyles, and the presence of venous insufficiency in Saudi Arabia. As these factors become more prevalent in Saudi Arabia, there is a subsequent rise in the incidence of venous leg ulcers. Therefore, due to these aspects, the market will expand across the LAMEA region in the coming years.

The Brazil market dominated the LAMEA Negative Pressure Wound Therapy Market, By Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $77 million by 2030. The Argentina market is showcasing a CAGR of 8.7% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 7.8% during (2023 - 2030).

Based on End-Use, the market is segmented into Hospitals, Homecare, and Others. Based on Product, the market is segmented into Conventional NPWT, and Single-use NPWT. Based on Type, the market is segmented into Pressure Ulcers, Diabetic Foot Ulcers, Venous Leg Ulcers, Burn Wounds, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

List of Key Companies Profiled

  • 3M Company
  • Talley Group Ltd. (Direct Healthcare Group)
  • Smith & Nephew PLC
  • Molnlycke Health Care AB
  • DeRoyal Industries, Inc.
  • ConvaTec Group PLC
  • Cardinal Health, Inc.
  • HARTMANN Group (Paul Hartmann AG)
  • Cork Medical, LLC

Market Report Segmentation

By End-Use
  • Hospitals
  • Homecare
  • Others
By Product
  • Conventional NPWT
  • Single-use NPWT
By Type
  • Pressure Ulcers
  • Diabetic Foot Ulcers
  • Venous Leg Ulcers
  • Burn Wounds
  • Others
By Country
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Negative Pressure Wound Therapy Market, by End-Use
1.4.2 LAMEA Negative Pressure Wound Therapy Market, by Product
1.4.3 LAMEA Negative Pressure Wound Therapy Market, by Type
1.4.4 LAMEA Negative Pressure Wound Therapy Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Opportunities
3.2.3 Market Restraints
3.2.4 Market Challenges
3.3 Porter’s Five Forces Analysis
Chapter 4. LAMEA Negative Pressure Wound Therapy Market, By End-Use
4.1 LAMEA Hospitals Market, By Country
4.2 LAMEA Homecare Market, By Country
4.3 LAMEA Others Market, By Country
Chapter 5. LAMEA Negative Pressure Wound Therapy Market, By Product
5.1 LAMEA Conventional NPWT Market, By Country
5.2 LAMEA Single-use NPWT Market, By Country
Chapter 6. LAMEA Negative Pressure Wound Therapy Market, By Type
6.1 LAMEA Pressure Ulcers Market, By Country
6.2 LAMEA Diabetic Foot Ulcers Market, By Country
6.3 LAMEA Venous Leg Ulcers Market, By Country
6.4 LAMEA Burn Wounds Market, By Country
6.5 LAMEA Others Market, By Country
Chapter 7. LAMEA Negative Pressure Wound Therapy Market, By Country
7.1 Brazil Negative Pressure Wound Therapy Market
7.1.1 Brazil Negative Pressure Wound Therapy Market, By End-Use
7.1.2 Brazil Negative Pressure Wound Therapy Market, By Product
7.1.3 Brazil Negative Pressure Wound Therapy Market, By Type
7.2 Argentina Negative Pressure Wound Therapy Market
7.2.1 Argentina Negative Pressure Wound Therapy Market, By End-Use
7.2.2 Argentina Negative Pressure Wound Therapy Market, By Product
7.2.3 Argentina Negative Pressure Wound Therapy Market, By Type
7.3 UAE Negative Pressure Wound Therapy Market
7.3.1 UAE Negative Pressure Wound Therapy Market, By End-Use
7.3.2 UAE Negative Pressure Wound Therapy Market, By Product
7.3.3 UAE Negative Pressure Wound Therapy Market, By Type
7.4 Saudi Arabia Negative Pressure Wound Therapy Market
7.4.1 Saudi Arabia Negative Pressure Wound Therapy Market, By End-Use
7.4.2 Saudi Arabia Negative Pressure Wound Therapy Market, By Product
7.4.3 Saudi Arabia Negative Pressure Wound Therapy Market, By Type
7.5 South Africa Negative Pressure Wound Therapy Market
7.5.1 South Africa Negative Pressure Wound Therapy Market, By End-Use
7.5.2 South Africa Negative Pressure Wound Therapy Market, By Product
7.5.3 South Africa Negative Pressure Wound Therapy Market, By Type
7.6 Nigeria Negative Pressure Wound Therapy Market
7.6.1 Nigeria Negative Pressure Wound Therapy Market, By End-Use
7.6.2 Nigeria Negative Pressure Wound Therapy Market, By Product
7.6.3 Nigeria Negative Pressure Wound Therapy Market, By Type
7.7 Rest of LAMEA Negative Pressure Wound Therapy Market
7.7.1 Rest of LAMEA Negative Pressure Wound Therapy Market, By End-Use
7.7.2 Rest of LAMEA Negative Pressure Wound Therapy Market, By Product
7.7.3 Rest of LAMEA Negative Pressure Wound Therapy Market, By Type
Chapter 8. Company Profiles
8.1 DeRoyal Industries, Inc.
8.1.1 Company Overview
8.2 Cork Medical, LLC
8.2.1 Company Overview
8.2.2 Recent strategies and developments:
8.2.2.1 Product Launches and Product Expansions:
8.3 3M Company
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Product Launches and Product Expansions:
8.3.5.2 Acquisition and Mergers:
8.3.6 SWOT Analysis
8.4 Talley Group Ltd. (Direct Healthcare Group)
8.4.1 Company Overview
8.5 Smith & Nephew PLC
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional and Segmental Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Product Launches and Product Expansions:
8.5.6 SWOT Analysis
8.6 Molnlycke Health Care AB
8.6.1 Company Overview
8.6.2 Recent strategies and developments:
8.6.2.1 Product Launches and Product Expansions:
8.6.3 SWOT Analysis
8.7 ConvaTec Group PLC
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 SWOT Analysis
8.8 Cardinal Health, Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 SWOT Analysis
8.9 HARTMANN Group (Paul Hartmann AG)
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expenses
8.9.5 Recent strategies and developments:
8.9.5.1 Acquisition and Mergers:
8.9.6 SWOT Analysis

Companies Mentioned

  • 3M Company
  • Talley Group Ltd. (Direct Healthcare Group)
  • Smith & Nephew PLC
  • Molnlycke Health Care AB
  • DeRoyal Industries, Inc.
  • ConvaTec Group PLC
  • Cardinal Health, Inc.
  • HARTMANN Group (Paul Hartmann AG)
  • Cork Medical, LLC

Methodology

Loading
LOADING...